We believe the scientific community goes further, faster when we go there together. We provide the research and clinical communities with expert scientific support, highly validated antibodies, assays, and other tools to address important targets in critical biological pathways. Today, we help 750,000 researchers in over 130 countries reach results faster in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders.

Progress happens together

Our challenge

Antibodies are the beating heart of biotech. Whether as a therapeutic, or as a tool of detection, they are fundamental.

The search for antibodies with the necessary sensitivity, specificity and consistency for this range of applications is a constant challenge.

Meeting the challenge

We harness data-driven insights to identify, develop and provide the newest and best biological binders available globally.

We embed quality and validation into all our processes to support the drive for accurate and reproducible scientific research.

We question the status quo, empowering life scientists to break through barriers to progress

​We continuously seek out customer feedback and R&D collaborations to anticipate problems before they come up and solve them.

We build on technical and scientific advancements to enhance how we develop, produce and deliver our products, so that you can go further, faster.

Our people

Our team is our biggest asset. We have over 1,100 employees, across eleven sites globally, who thrive on deploying their in-depth knowledge and expertise.

Our products

We supply the global life science community with antibodies, reagents and kits that are supported by detailed data - from handling and recommended use, to validation results, user comments, and peer-reviewed citations.

Our products combine biology and data, together with expert customer support and fast delivery.

Key ranges:

• Primary antibodies
• ​Secondary antibodies
• ​ELISA
• Matched antibody pairs
• Knockout cell lines
• Accessories and reagents
• ​Proteins and peptides

Our partnerships

​We have the experience and capabilities to partner with life science organizations to co-create antibodies as key reagents in drug discovery, in vitro diagnostics, and therapeutics.

​We offer world-leading data-driven expertise in antibodies and proprietary antibody discovery platforms.

We can provide full-cycle support, all the way from antibody identification and development, to validation, pre-clinical selection, licensing, and commercialization.

Fueling the engine of research

We supply two thirds of the world's life scientists with over 110,000 products to research protein targets - across antibodies, proteins, lysates, biochemicals, kits and assays.

​We manufacture our own products in our specialist facilities worldwide, as well as sourcing from over 400 partners.

Collaborating with the Life Sciences industry to enable the development of tomorrow's medicines.

Abcam is proud to be part of Danaher.

Abcam is proud to be part of Danaher, a global life sciences and diagnostics innovator committed to accelerating the power of science and technology to improve human health.

As part of Danaher, Abcam is connected to a uniquely broad ecosystem of expertise, technologies, and capabilities. Together, we partner closely with customers to help solve their toughest challenges with greater speed and certainty.

Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow.